Navigation Links
AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
Date:5/29/2008

AMSTERDAM, May 30 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that positive interim data from its pivotal clinical trial with AMT's lead product Glybera(R) (AMT-011) were presented by the Principal Investigator, professor Daniel Gaudet, at the American Society of Gene Therapy Annual Meeting in Boston on May 29th. These data confirm the outcome of a previous study conducted in The Netherlands, demonstrating safety and efficacy of Glybera(R) for lipoprotein-lipase deficiency, a disease also known as Hyperlipoproteinemia (HPL) type I. Currently, there is no effective treatment or cure for this seriously debilitating and potentially lethal disease.

Study data

Glybera(R) is a gene therapy product that corrects the genetic defect in lipoprotein-lipase (LPL) deficient patients. LPL is normally produced in muscle tissue and is needed to break down the large fat-carrying particles that circulate in the blood after each meal. As a result, LPL-deficient patients have very high fat (triglyceride) levels in their blood which may lead to recurrent episodes of pancreatitis, insulin resistance, and fat accumulations in skin as well as liver and retina.

In the pivotal study conducted in Quebec (Canada), patients with LPL-deficiency were first enrolled in an observation study and subsequently treated in a study in which there are two different dose groups. All patients showed very high fat levels in the observation study and had experienced (recurrent) pancreatitis episodes prior to treatment. To date 6 patients have been treated with the lower dose and 7 with the higher dose.

Professor Gaudet presented data on the first 10 patients, of which 6 were in the lower dose group and 4 were in the higher dose group. The data showed that treatment was well tolerated. Fat concentrations were reduced after treatment in all patients, with one exception. In all patients
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 A six-hour certification program on ... presented at the Cannabis World Congress & Business Exposition ... York, NY .  Taking place on Wednesday, June 17 ... of education at the leading event on the East Coast ... Led by Clover Leaf University, the first cannabis university to ...
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hgs483/cardiovascular ) ... report "Cardiovascular Drug Delivery - Technologies, Markets ... Drug delivery to the cardiovascular system is different ... anatomy and physiology of the vascular system; it ... the body. Drugs can be introduced into the ...
(Date:5/29/2015)... Research and Markets ( ... "Surgical/Operating Microscopes Market by Application & End ... to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... poised to reach $806.6 million by 2020 from ... 12.3% from 2015 to 2020. , ,Major factors ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... BD (Becton, Dickinson and Company) (NYSE: BDX ... revenues of $2.051 billion for the fourth fiscal quarter ended ... the prior-year period, or 4.0 percent on a foreign currency-neutral ... September 30, 2011, BD reported revenues of $7.829 billion, representing ...
... NEW YORK, Nov. 1, 2011 Keryx Biopharmaceuticals, Inc. ... on the acquisition, development and commercialization of medically important ... disease, today announced that a conference call will be ... EDT to discuss results for the third quarter ended ...
Cached Medicine Technology:BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 2BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 3BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 4BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 5BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 6BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 7BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 8BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 9BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 10BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 11BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 12BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 13Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results 2
(Date:5/29/2015)... 29, 2015 The science of hair ... Angeles thanks to the efforts of internationally recognized hair ... combined ARTAS hair restoration and manual FUE ... procedures available anywhere. , A Follicular Unit Extraction ... harvesting hair follicle grafts from the donor areas of ...
(Date:5/29/2015)... CO (PRWEB) May 29, 2015 ... new addiction, substance abuse, and co-occurring mental health ... and ribbon cutting for the general public on ... 2nd. , The Recovery Village at Palmer Lake ... intensive outpatient programming, utilizing traditional and evidence-based therapies, ...
(Date:5/29/2015)... 29, 2015 Red Hot & Blue ... Red Hot & Blue restaurant at 525 New Waverly Place ... 7, 2015. “The Red Hot & Blue Restaurant was previously ... but we have moved to a new location in the ... middle of all the activities on the Promenade–with outdoor seating ...
(Date:5/29/2015)... 2015 A group of doctors have discovered ... national effort to teach this “new math” to children in ... been “sickened” by the recent implementation of Common Core Math ... it, Common Core is now a reality in children’s classrooms ... are now seeking ways to improve common core math training ...
(Date:5/29/2015)... has joined forces with Raw Elements Physical Eco Protection ... sun protection. The print component of “Skin Health” is ... 250,000 copies and an estimated readership of 750,000 readers. ... social media strategy, and across a network of top ... version of the campaign, click here . ...
Breaking Medicine News(10 mins):Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Doctors Discover a Cure for the Common Core 2
... advanced colorectal neoplasms was lower in participants in a ... received a colonoscopy in the preceding 10 years, according ... the Journal of the National Cancer Institute . ... been studied, but evidence from community settings is sparse, ...
... untreated, plantar fasciitis can lead to other problems, doctor says ... injuries" may bring to mind tennis elbow and jogger,s knee, ... of injury due to overuse, doctors warn. , The condition, ... of the foot, can become chronic if steps aren,t taken ...
... in otherwise healthy nonsmoking adults, study finds , WEDNESDAY, ... smokers face a higher risk of early emphysema when ... totally recovered from secondhand smoke exposure, new research suggests. ... scans on 1,781 non-smokers from six communities in the ...
... , WASHINGTON, Dec. 30 BIO Ventures for ... Chief Executive Officer of the global health non-profit. Moree has ... July 2009 and has been a member of the board of ... for Global Health as interim CEO, she served as Executive Director ...
... although legal, and adults use it widely to perk themselves ... But how strong is caffeine,s appeal in ... What impact does acute and chronic caffeine consumption have on ... does consuming caffeinated drinks during adolescence contribute to later use ...
... one day take potent therapies, get heart fixed later, researchers ... types of chemotherapy can damage the heart while thwarting cancer, ... new study in rats finds that injecting the heart with ... anti-cancer drug. , , The findings could one day mean ...
Cached Medicine News:Health News:Fewer left-sided colorectal tumors observed after colonoscopies 2Health News:Heel Pain Usually Relieved With Stretching Regimen 2Health News:BIO Ventures for Global Health Announces New CEO 2Health News:BIO Ventures for Global Health Announces New CEO 3Health News:Addictive effects of caffeine on kids being studied by UB neurobiologist 2Health News:Addictive effects of caffeine on kids being studied by UB neurobiologist 3Health News:Stem Cells Might Reverse Heart Damage From Chemo 2Health News:Stem Cells Might Reverse Heart Damage From Chemo 3
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
Clear Base Stand Magnifiers are ideal for any visual task that requires high magnification....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
Medicine Products: